Cure My Disease

Don't miss your cure!

 Log in / Sign up

Virtual basket laser mode put to the test for faster prostate surgery

NCT ID NCT07816484

Symptom relief Sponsor: Mansoura University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 11, 2026 · Last updated Sep 11, 2026

Summary

Researchers at Mansoura University are comparing two settings of holmium laser enucleation of the prostate (HoLEP) in men with symptomatic benign prostatic hyperplasia (BPH) and prostates of at least 80 cc. One group receives the standard laser setting, while the other receives a virtual basket mode that adjusts the laser pulses. The trial measures how efficiently the prostate tissue is removed, calculated as resected volume divided by enucleation time, and also tracks urinary symptoms and sexual function. The goal is to see whether the virtual basket setting improves surgical efficiency without compromising safety.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Holmium:YAG laser enucleation of the prostate, tested with standard settings versus a virtual basket mode
What this could lead to
If the virtual basket mode works better, surgeons could remove enlarged prostate tissue faster and with less operating time, which may mean shorter anesthesia and quicker recovery for patients.
What could go wrong
This is a single-center study of 133 men with very large prostates, so results may not apply to smaller glands or other hospitals. Laser prostate surgery carries known risks of bleeding, infection, and temporary urinary problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

133 people

The number who actually took part.

Started

Jul 2025

Finished

Sep 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: LUTS secondary to BOO due to BPH with indication for surgical intervention: International prostate symptom scores (IPSS) \>15 and bother score (QOL) ≥ 3 (according to IPSS question 8) Peak urinary flow rate (Qmax) \<15 ml/sec with at least 150 ml voided volume or catheterized patients due to acute urine retention secondary to BPH who failed trial of voiding on medical treatment. ASA (American society of anesthesiologists) score ≤3. Prostate size as measured by TRUS ≥80 cc. Exclusion Criteria: Patient with neurological disorder which might affect bladder function as cerebrovascular stroke, Parkinson disease Active urinary tract infection (till treated by culture-based antibiotics) Presence of active bladder cancer. Known prostate cancer patients will be excluded preoperatively based on digital rectal examination, prostate specific antigen level, and TRUS imaging followed by prostate biopsies if necessary. Patient has had an acute myocardial infarction or open-heart surgery \<180 days prior to the date of informed consent. \-

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Benign prostatic hyperplasia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BPH/luts/sexual functions

Contacts and locations

Locations

  • Urology and Nephrology Center, Mnasoura University

    Al Mansurah, Dakahlia Governorate, 35561, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.